Newamsterdam Pharma Stock Probability of Future Stock Price Finishing Under 20.2
| NAMS Stock | 20.20 0.08 0.40% |
NewAmsterdam |
NewAmsterdam Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of NewAmsterdam Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for NewAmsterdam Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| NewAmsterdam Pharma had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 12.76 M. Net Loss for the year was (160.27 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NewAmsterdam Pharma generates negative cash flow from operations | |
| NewAmsterdam Pharma has a frail financial position based on the latest SEC disclosures | |
| Over 84.0% of the company shares are owned by institutional investors |
NewAmsterdam Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of NewAmsterdam Stock often depends not only on the future outlook of the current and potential NewAmsterdam Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NewAmsterdam Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 82.2 M | |
| Cash And Short Term Investments | 340.4 M |
NewAmsterdam Pharma Technical Analysis
NewAmsterdam Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. NewAmsterdam Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NewAmsterdam Pharma. In general, you should focus on analyzing NewAmsterdam Stock price patterns and their correlations with different microeconomic environments and drivers.
NewAmsterdam Pharma Predictive Forecast Models
NewAmsterdam Pharma's time-series forecasting models is one of many NewAmsterdam Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary NewAmsterdam Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about NewAmsterdam Pharma
Checking the ongoing alerts about NewAmsterdam Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for NewAmsterdam Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| NewAmsterdam Pharma had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 12.76 M. Net Loss for the year was (160.27 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NewAmsterdam Pharma generates negative cash flow from operations | |
| NewAmsterdam Pharma has a frail financial position based on the latest SEC disclosures | |
| Over 84.0% of the company shares are owned by institutional investors |
Additional Tools for NewAmsterdam Stock Analysis
When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.